Article
Rapid resistance profiling of SARS-CoV-2 protease inhibitors
2023-02-27
Abstract excerpt
Resistance to nirmatrelvir (Paxlovid) has been shown by multiple groups and may already exist in clinical SARS-CoV-2 isolates. Here a panel of SARS-CoV-2 main protease (M pro ) variants and a robust cell-based assay are used to compare the resistance profiles of nirmatrelvir, ensitrelvir, and FB2001. The results reveal distinct resistance mechanisms (“fingerprints”) and indicate that these next-generation drugs h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 22ed41de-77ac-571a-808b-5931e5df3f80
- DOI
- 10.1101/2023.02.25.530000
